about
A Systematic Review of the Impact of Exposure to Internet-Based Alcohol-Related Content on Young People's Alcohol Use Behaviours.Characteristics of individuals presenting to treatment for primary alcohol problems versus other drug problems in the Australian patient pathways study.Demographic and Substance Use Factors Associated with Non-Violent Alcohol-Related Injuries among Patrons of Australian Night-Time Entertainment Districts.Most recent risky drinking session with Australian teenagers.Social disadvantage and past treatment among clients entering public alcohol and drug services in two Australian states.Substance use outcomes following treatment: Findings from the Australian Patient Pathways Study.Comparing levels of blood alcohol concentration and indicators of impairment in nightlife patrons.Re-thinking pre-drinking: Implications from a sample of teenagers who drink in private settings.Pre-Drinking Behavior of Young Heavy Drinkers.Alcohol marketing on YouTube: exploratory analysis of content adaptation to enhance user engagement in different national contexts.Correlates of verbal and physical aggression among patrons of licensed venues in Australia.A comparative study of blood alcohol concentrations in Australian night-time entertainment districts.Youth perceptions of alcohol advertising: are current advertising regulations working?The association between exposure to social media alcohol marketing and youth alcohol use behaviors in India and Australia.Alcohol policy impact on young risky drinkers and their support for proposed measuresPrescribed sedative and other psychotropic medication use among clients attending alcohol and other drug treatmentInsomnia and Regulation of Sleep-Wake Cycle With Drugs Among Adolescent Risky DrinkersComparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018Alcohol supply as a favour for a friend: Scenarios of alcohol supply to younger friends and siblingsRecent trends in heroin and pharmaceutical opioid-related harms in Victoria, Australia up to 2018
P50
Q30244010-BB839704-9283-4CB5-8E66-DADB6A91825FQ36082057-4C8AE138-F034-4335-96F3-4F6F3001486EQ37628819-D4093967-928B-4467-B90C-F233489B529DQ39256013-19056F07-131A-4F76-A4F5-DCFA3129B1B7Q40048085-9B2AFB8D-E236-44B0-9185-1A808B187B37Q40105406-D82ABF19-18FC-435E-BAF6-4489DE5B3F96Q46590145-02F56544-647F-4E95-9E05-DDA062588807Q47302251-EB1814F9-B0A9-47C5-9EA5-B7131F40A4B7Q47425603-A93A15EF-02F5-4AD4-B76C-7153E318C66DQ47558783-CCC5457B-C23F-451A-BA8F-7FFBA25C9D6DQ48063001-57E45043-0DC3-4930-A77D-847753A60A81Q51709480-30556A1B-6927-47DB-B381-51AE94604F87Q52561521-0DBC7765-43A0-49FC-9FED-6D4FAB3588B4Q55410766-C915EC3E-0157-4730-9288-6D83F349D4D3Q57838966-267A9928-8F93-4ED2-AD7F-294965477322Q89468229-BE2B68F9-F565-4CDE-A592-F91CA6EF1EC0Q91273985-22422921-6B46-4702-B7DE-3BF7AB9358CDQ91336736-A24E0252-4B25-425D-86C9-CA4525E601F2Q92598751-BB1B7B3A-B9BA-4D7F-A23F-FA9FEEA2A2E7Q92980229-C372883F-AE7C-47B0-8D76-A167C35A9EB6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tina Lam
@ast
Tina Lam
@en
Tina Lam
@es
Tina Lam
@nl
type
label
Tina Lam
@ast
Tina Lam
@en
Tina Lam
@es
Tina Lam
@nl
prefLabel
Tina Lam
@ast
Tina Lam
@en
Tina Lam
@es
Tina Lam
@nl
P106
P1153
56272213200
P31
P496
0000-0002-4902-7293